The stock market indices had a rough session. After a gap up and then a move up to resistance, the indices were unable to get much further than that. They had a selloff, a very sharp snapback, but again couldn’t get through the highs, and then started to decline in a distinct down-channel all day. Only in the last hour did they snap back off the lows, but S&P 500 violated key support by a couple points, before the rally. We’ll just have to see whether they were able to hold the fort right here, or going to make lower lows.

Net on the day, the Dow was down 85.40 at 18,168.45, about 58 points off the low. The S&P 500 was down 10.71 at 2150.49, 6 points off its low. The Nasdaq 100 was down 7.16 at 4859.47.

Advance-declines were 2 1/2, almost 3 to 1 negative on the New York Stock Exchange, and 17 to 10 negative on the Nasdaq. Up/down volume was 2 1/2 to 1 negative on New York, total volume of 3.7 billion shares traded. The Nasdaq traded 1 2/3 billion shares and had a 5 to 3 negative volume ratio.

TheTechTrader.com was better today than the S&P 500 because of some major players, such as Priceline.com (PCLN) was up 2.30 to 1489.02, Google Inc. (GOOG) up 3.87 to 776.43, Apple Inc. (AAPL) 48 cents to 113.00, but Amazon.com Inc. (AMZN) lost 2.71 to 834.03, and Netflix, Inc. (NFLX) gave back 29 cents to 102.34.

Baidu, Inc. (BIDU) gained 54 cents to 184.08, Facebook, Inc. (FB) was down 59 cents to 128.18, and First Solar, Inc. (FSLR) dropped 36 cents to 38.21. Microsoft Corporation (MSFT) was in the red for 18 cents to 57.24, Intel Corporation (INTC) closed down 12 cents to 37.54.

Tesla Motors, Inc. (TSLA) lost 2.29 to 211.41.

In addition, the only other point-plus losers on our board was Puma Biotechnology, Inc. (PBYI), in a weak biotech sector, down 1.64 to 62.54.

Checking TheTechTrader.com percent-gain leaderboard, Ocera Therapeutics, Inc. (OCRX) bounced 23 cents, or 9%, to 2.92, on 1.8 million shares traded.

Summit Therapeutics plc (SMMT) exploded on positive drug news, up 5.70, or 66%, to 14.35, on 4.8 million shares traded, reaching as high as 19 3/4 after the opening, but moved all the way down to 13, and change, before bouncing way off of 11, and change, from earlier in the day.

Advaxis, Inc. (ADXS) climbed 1.10, or 10%, to 1206, on 1.6 million shares traded. Editas Medicine Inc. (EDIT) bounced 1.43, or 11%, to 14.92, Momo Inc. (MOMO) was up 2.39, or 11%, to 24.48, on 6.4 million shares traded.

The Direxion Daily Gold Miners Bear 3X ETF (DUST) was up 10.46, or 30%, to 46.08, or 16.6 million shares traded. The Direxion Daily Jr Gld Mnrs Bear 3X ETF (JDST) ran 7.92, or 31%, to 33.20, on 9.7 million shares traded.

The VelocityShares 3x Long Natural Gas ETN (UGAZ) thrust 2.21 to 38.67.

Stepping back and reviewing the hourly chart patterns, the indices had an early pop, and then they went down all session until the last half hour when they snapped out of the declining channel, although a late pullback did push them back a little bit.

It wasn’t as bad a day as it appeared on the surface.

Let’s see what happens tomorrow.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.